Mercury Laboratories Approves Unaudiited Financial Results for Quarter Ended June 30, 2026
Mercury Laboratories Ltd. has approved the unaudited financial results for the quarter ended on June 30, 2026. The Board of Directors ratified these results during a meeting held in Vadodara on July 25, 2026. These results provide insight into the company's operational and financial performance across various periods.The unaudited statements were reviewed by the Audit Committee before being approved by the Board. Statutory Auditors also conducted a Limited Review of the results for the quarter ended June 30, 2026.
Financial Performance Overview
The unaudited Statement of Financial Results for the quarter ended on June 30, 2026, shows key financial metrics across comparison periods (in lakhs).| Particulars | Quarter Ended 30.06.2026 (Unaudited) | Quarter Ended 31.03.2026 (Audited) | Quarter Ended 30.06.2025 (Unaudited) | Year Ended 31.03.2026 (Audited) |
|---|---|---|---|---|
| Total Income | 1,601.54 | 2,111.33 | 1,831.64 | 7,789.18 |
| Cost of materials consumed | 579.14 | 690.03 | 593.83 | - |
| Purchase of Traded Goods | 65.01 | 75.24 | 33.78 | 227.60 |
| Changes in inventories of finished goods, work in process | (34.83) | 19.29 | 97.40 | 189.15 |
| Employee benefits expense | - | - | - | - |
| Finance Costs | 12.30 | 13.05 | 14.53 | 54.48 |
| Depreciation/Amortization expense | - | 84.3'1, | 84.3', | - |
| Other Expenses | 444.19 | 598.23 | 428.77 | 1,993.55 |
| Total Expenses | 1,562.35 | 1,937.65 | 1,676.91 | 7,085.97 |
| Profit before Tax | 39.19 | 173.68 | 154.73 | 663.72 |
| Net Profit after Tax (NPAT) | 29.78 | 122.54 | 96.76 | 483.40 |
Comprehensive Income Details
The results also detail the company's comprehensive income for the period:- Total Other Comprehensive Income: The figures included various components such as items relating to profit or loss remeasurement of net defined benefit liability/assets, and income tax relating to those items.
- Total Comprehensive Income: For the period ended June 30, 2026, total comprehensive income stood at 96.91.
The company maintains a focus on the single segment of "Pharmaceuticals Products."
Stock Price Movement
Mercury Laboratories Ltd shares settled at ₹835.00 on Friday after ticking up a strong 3.37%. The stock remained completely flat throughout the trading session, holding steady at this price point across its intraday range.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.